"...phase 1, 20 patients in 4 arms, start stop trial, all work, 1 works, does not matter, rolls into a phase 3, 50 patients each arm, 3 mos if people work hard, 4 mos no later a completed vaccine and approval, no one can touch that period. They need 5.5 million for their vaccine, read my Agreement in the 8k I’m not paying them anywhere near that or even 500k for that matter, just ridiculous all these assumptions..."
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links